Cetera Investment Advisers Lowers Holdings in Avantor, Inc. (NYSE:AVTR)

Cetera Investment Advisers lessened its holdings in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 47.5% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 21,519 shares of the company's stock after selling 19,444 shares during the quarter. Cetera Investment Advisers' holdings in Avantor were worth $453,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Louisiana State Employees Retirement System increased its stake in Avantor by 0.3% in the fourth quarter. Louisiana State Employees Retirement System now owns 188,900 shares of the company's stock valued at $3,980,000 after purchasing an additional 500 shares during the last quarter. Blue Trust Inc. increased its stake in Avantor by 6.9% in the fourth quarter. Blue Trust Inc. now owns 8,069 shares of the company's stock valued at $170,000 after purchasing an additional 522 shares during the last quarter. Pacer Advisors Inc. increased its stake in Avantor by 0.5% in the fourth quarter. Pacer Advisors Inc. now owns 99,825 shares of the company's stock valued at $2,103,000 after purchasing an additional 542 shares during the last quarter. Oregon Public Employees Retirement Fund increased its stake in Avantor by 0.6% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 138,465 shares of the company's stock valued at $2,917,000 after purchasing an additional 765 shares during the last quarter. Finally, Smartleaf Asset Management LLC increased its stake in Avantor by 106.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock valued at $34,000 after purchasing an additional 830 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company's stock.

Avantor Price Performance

Avantor stock traded down $0.13 during midday trading on Friday, reaching $12.91. The company's stock had a trading volume of 11,443,298 shares, compared to its average volume of 7,958,956. Avantor, Inc. has a fifty-two week low of $11.82 and a fifty-two week high of $28.00. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07. The stock's 50 day simple moving average is $14.08 and its 200 day simple moving average is $17.91. The firm has a market capitalization of $8.80 billion, a PE ratio of 12.41, a P/E/G ratio of 1.55 and a beta of 1.09.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $0.23 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.23. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a return on equity of 12.17% and a net margin of 10.49%. The business's revenue was down 5.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.22 EPS. On average, equities research analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have commented on AVTR. Royal Bank of Canada dropped their price target on shares of Avantor from $24.00 to $20.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Wells Fargo & Company lowered their target price on shares of Avantor from $25.00 to $22.00 and set an "overweight" rating on the stock in a research report on Thursday, April 17th. Cowen lowered shares of Avantor from a "buy" rating to a "hold" rating in a research report on Monday, April 28th. TD Cowen lowered shares of Avantor from a "buy" rating to a "hold" rating and set a $15.50 target price on the stock. in a research report on Monday, April 28th. Finally, Robert W. Baird lowered their target price on shares of Avantor from $21.00 to $17.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Seven investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, Avantor has an average rating of "Hold" and a consensus target price of $18.88.

Insider Transactions at Avantor

In other news, Director Joseph R. Massaro bought 8,100 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The stock was purchased at an average price of $12.30 per share, with a total value of $99,630.00. Following the purchase, the director now owns 35,038 shares of the company's stock, valued at $430,967.40. This trade represents a 30.07% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Gregory L. Summe bought 30,000 shares of the business's stock in a transaction that occurred on Friday, May 23rd. The stock was purchased at an average cost of $12.50 per share, with a total value of $375,000.00. Following the purchase, the director now directly owns 100,000 shares in the company, valued at $1,250,000. The trade was a 42.86% increase in their position. The disclosure for this purchase can be found here. Insiders bought 83,100 shares of company stock valued at $1,027,630 in the last 90 days. 1.20% of the stock is currently owned by insiders.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.